Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23447001 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma
Condition: Relapsed Multiple Myeloma
Interventions: Drug: Carfilzomib;   Drug: Lenalidomide;   Drug: Dexamethasone

Study has passed its completion date and status has not been verified in more than two years.